These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34329692)

  • 1. Changes in the gut microbiome influence the hypoglycemic effect of metformin through the altered metabolism of branched-chain and nonessential amino acids.
    Lee Y; Kim AH; Kim E; Lee S; Yu KS; Jang IJ; Chung JY; Cho JY
    Diabetes Res Clin Pract; 2021 Aug; 178():108985. PubMed ID: 34329692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
    Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
    Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin Strongly Affects Gut Microbiome Composition in High-Fat Diet-Induced Type 2 Diabetes Mouse Model of Both Sexes.
    Silamiķele L; Silamiķelis I; Ustinova M; Kalniņa Z; Elbere I; Petrovska R; Kalniņa I; Kloviņš J
    Front Endocrinol (Lausanne); 2021; 12():626359. PubMed ID: 33815284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus.
    Lee CB; Chae SU; Jo SJ; Jerng UM; Bae SK
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of vancomycin-induced gut microbiome alteration on the pharmacodynamics of metformin in healthy male subjects.
    Kim E; Kim AH; Lee Y; Ji SC; Cho JY; Yu KS; Chung JY
    Clin Transl Sci; 2021 Sep; 14(5):1955-1966. PubMed ID: 33982376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of combination treatment with metformin and berberine on hypoglycemic activity and gut microbiota modulation in db/db mice.
    Lyu Y; Li D; Yuan X; Li Z; Zhang J; Ming X; Shaw PC; Zhang C; Kong APS; Zuo Z
    Phytomedicine; 2022 Jul; 101():154099. PubMed ID: 35489323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of gut microbiota in type 2 diabetes to hypoglycemic agents.
    Zhang F; Wang M; Yang J; Xu Q; Liang C; Chen B; Zhang J; Yang Y; Wang H; Shang Y; Wang Y; Mu X; Zhu D; Zhang C; Yao M; Zhang L
    Endocrine; 2019 Dec; 66(3):485-493. PubMed ID: 31410749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Integrated Fecal Microbiome and Metabolomics in T2DM Rats Reveal Antidiabetes Effects from Host-Microbial Metabolic Axis of EtOAc Extract from
    Shao J; Liu Y; Wang H; Luo Y; Chen L
    Oxid Med Cell Longev; 2020; 2020():1805418. PubMed ID: 32566075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Gut Microbiome, Metformin, and Aging.
    Induri SNR; Kansara P; Thomas SC; Xu F; Saxena D; Li X
    Annu Rev Pharmacol Toxicol; 2022 Jan; 62():85-108. PubMed ID: 34449247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic modelling of the human gut microbiome in type 2 diabetes patients in response to metformin treatment.
    Ezzamouri B; Rosario D; Bidkhori G; Lee S; Uhlen M; Shoaie S
    NPJ Syst Biol Appl; 2023 Jan; 9(1):2. PubMed ID: 36681701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus.
    Foretz M; Guigas B; Viollet B
    Nat Rev Endocrinol; 2019 Oct; 15(10):569-589. PubMed ID: 31439934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin: old friend, new ways of action-implication of the gut microbiome?
    Rodriguez J; Hiel S; Delzenne NM
    Curr Opin Clin Nutr Metab Care; 2018 Jul; 21(4):294-301. PubMed ID: 29634493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive Probio-X Treatment Enhances the Therapeutic Effect of a Conventional Drug in Managing Type 2 Diabetes Mellitus by Promoting Short-Chain Fatty Acid-Producing Bacteria and Bile Acid Pathways.
    Chen Y; Shen X; Ma T; Yu X; Kwok LY; Li Y; Sun Z; Li D; Zhang H
    mSystems; 2023 Feb; 8(1):e0130022. PubMed ID: 36688679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: new insights into old diseases.
    Pascale A; Marchesi N; Govoni S; Coppola A; Gazzaruso C
    Curr Opin Pharmacol; 2019 Dec; 49():1-5. PubMed ID: 31015106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.
    Forslund K; Hildebrand F; Nielsen T; Falony G; Le Chatelier E; Sunagawa S; Prifti E; Vieira-Silva S; Gudmundsdottir V; Pedersen HK; Arumugam M; Kristiansen K; Voigt AY; Vestergaard H; Hercog R; Costea PI; Kultima JR; Li J; Jørgensen T; Levenez F; Dore J; ; Nielsen HB; Brunak S; Raes J; Hansen T; Wang J; Ehrlich SD; Bork P; Pedersen O
    Nature; 2015 Dec; 528(7581):262-266. PubMed ID: 26633628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut.
    de la Cuesta-Zuluaga J; Mueller NT; Corrales-Agudelo V; Velásquez-Mejía EP; Carmona JA; Abad JM; Escobar JS
    Diabetes Care; 2017 Jan; 40(1):54-62. PubMed ID: 27999002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleiotropic effects of metformin: Shaping the microbiome to manage type 2 diabetes and postpone ageing.
    Prattichizzo F; Giuliani A; Mensà E; Sabbatinelli J; De Nigris V; Rippo MR; La Sala L; Procopio AD; Olivieri F; Ceriello A
    Ageing Res Rev; 2018 Dec; 48():87-98. PubMed ID: 30336272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic switching in the hypoglycemic and antitumor effects of metformin on high glucose induced HepG2 cells.
    Lv Y; Tian N; Wang J; Yang M; Kong L
    J Pharm Biomed Anal; 2018 Jul; 156():153-162. PubMed ID: 29705631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin Affects Gut Microbiome Composition and Function and Circulating Short-Chain Fatty Acids: A Randomized Trial.
    Mueller NT; Differding MK; Zhang M; Maruthur NM; Juraschek SP; Miller ER; Appel LJ; Yeh HC
    Diabetes Care; 2021 Jul; 44(7):1462-1471. PubMed ID: 34006565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.